Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure-Reference-Cited by-同舟云学术

Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure

Published:2021-11 Issue: Volume:50 Page:116421
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Garai Sumanta,Schaffer Peter C.,Laprairie Robert B.,Janero David R.,Pertwee Roger G.,Straiker Alex,Thakur Ganesh A.

Funder

Canadian Institutes of Health Research

National Institutes of Health

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference49 articles.

1. Endocannabinoids and their pharmacological actions;Pertwee;Handb Exp Pharmacol,2015

2. Cannabinoid receptor type-1: breaking the dogmas;Busquets Garcia;F1000Res,2016

3. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome;Vemuri;Physiol Behav,2008

4. Cannabinoid signaling in health and disease;Lu;Can J Physiol Pharmacol,2017

5. Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists;Janero;Expert Opin Emerg Drugs,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positive allosteric modulation of the cannabinoid CB₁ receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kinetics;British Journal of Pharmacology;2024-06-03

2. Determination of the Cannabinoid CB1 Receptor’s Positive Allosteric Modulator Binding Site through Mutagenesis Studies;Pharmaceuticals;2024-01-24

3. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years;Pharmacological Reviews;2023-05-10

4. In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1H-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?;ACS Pharmacology & Translational Science;2022-11-22

5. Endocannabinoid signaling in the central nervous system;Glia;2022-10-29